최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Child’s nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, v.28 no.11, 2012년, pp.1879 - 1886
Lee, Kyung-Hwa , Kang, Kyung-Joo , Moon, Kyung-Sub , Jung, Tae-Young , Jung, Shin , Kim, Jae-Hyoo , Kim, Hyung-Seok , Lee, Min-Cheol
Glioblastomas are the most malignant tumors of central nervous system neoplasms and are well known for their biological heterogeneity. Contrary to the putative hypothesis of purely glial differentiation in glioblastomas, they often demonstrate immunopositivity for neuronal markers. However, the sign...
Mod Pathol B Bodey 4 742 1991 Bodey B, Cosgrove M, Gonzalez-Gomez I, Siegel SE, Martin SE, Gilles FH (1991) Co-expression of four intermediate filament subclasses in childhood glial neoplasms. Mod Pathol 4:742-749
Am J Surg Pathol M Cosgrove 13 141 1989 10.1097/00000478-198902000-00007 Cosgrove M, Fitzgibbons PL, Sherrod A, Chandrasoma PT, Martin SE (1989) Intermediate filament expression in astrocytic neoplasms. Am J Surg Pathol 13:141-145
Acta Neuropathol F Dehghani 95 493 1998 10.1007/s004010050830 Dehghani F, Schachenmayr W, Laun A, Korf HW (1998) Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases. Acta Neuropathol 95:493-504
Acta Neuropathol F Dehghani 100 122 2000 10.1007/s004010050003 Dehghani F, Maronde E, Schachenmayr W, Korf HW (2000) Neurofilament H immunoreaction in oligodendrogliomas as demonstrated by a new polyclonal antibody. Acta Neuropathol 100:122-130
Neuropathol Appl Neurobiol K Donev 36 411 2010 10.1111/j.1365-2990.2010.01078.x Donev K, Scheithauer BW, Rodriguez FJ, Jenkins S (2010) Expression of diagnostic neuronal markers and outcome in glioblastoma. Neuropathol Appl Neurobiol 36:411-421
Am J Pathol FE Franke 139 67 1991 Franke FE, Schachenmayr W, Osborn M, Altmannsberger M (1991) Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors. Am J Pathol 139:67-79
Cancer Res WA Freije 64 6503 2004 10.1158/0008-5472.CAN-04-0452 Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF (2004) Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64:6503-6510
Am J Surg Pathol C Giannini 26 479 2002 10.1097/00000478-200204000-00010 Giannini C, Scheithauer BW, Lopes MB, Hirose T, Kros JM, VandenBerg SR (2002) Immunophenotype of pleomorphic xanthoastrocytoma. Am J Surg Pathol 26:479-485
Acta Neuropathol C Hartmann 120 707 2010 10.1007/s00401-010-0781-z Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, Westphal M, Schackert G, Meyermann R, Pietsch T, Reifenberger G, Weller M, Loeffler M, von Deimling A (2010) Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol 120:707-718
Clin Neuropathol J Hirato 13 1 1994 Hirato J, Nakazato Y, Ogawa A (1994) Expression of non-glial intermediate filament proteins in gliomas. Clin Neuropathol 13:1-11
Arch Pathol Lab Med CD Katsetos 125 613 2001 10.5858/2001-125-0613-ALOTNC Katsetos CD, Del Valle L, Geddes JF, Assimakopoulou M, Legido A, Boyd JC, Balin B, Parikh NA, Maraziotis T, de Chadarevian JP, Varakis JN, Matsas R, Spano A, Frankfurter A, Herman MM, Khalili K (2001) Aberrant localization of the neuronal class III beta-tubulin in astrocytomas. Arch Pathol Lab Med 125:613-624
Neurol Med Chir (Tokyo) T Kawataki 50 228 2010 10.2176/nmc.50.228 Kawataki T, Sato E, Sato T, Kinouchi H (2010) Anaplastic ganglioglioma with malignant features in both neuronal and glial components-case report. Neurol Med Chir (Tokyo) 50:228-231
Neuropathology KJ Kim 31 494 2011 10.1111/j.1440-1789.2010.01194.x Kim KJ, Lee KH, Kim HS, Moon KS, Jung TY, Jung S, Lee MC (2011) The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology 31:494-502
P Kleuhues 33 2007 WHO classification of tumours of the central nervous system Kleuhues P, Burger PC, Aldepe KD, Brat DJ, Biernat W, Binger DD, Nakazato Y, Plate KH, Giangaspero F, von Deimling A, Ohgaki H, Cavenee WK (2007) Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC, Lyon, pp 33-49
J Neuropathol Exp Neurol C Labrakakis 56 243 1997 10.1097/00005072-199703000-00003 Labrakakis C, Patt S, Weydt P, Cervos-Navarro J, Meyer R, Kettenmann H (1997) Action potential-generating cells in human glioblastomas. J Neuropathol Exp Neurol 56:243-254
Acta Neuropathol MB Lopes 91 368 1996 10.1007/s004010050438 Lopes MB, Altermatt HJ, Scheithauer BW, Shepherd CW, VandenBerg SR (1996) Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathol 91:368-375
Arch Pathol Lab Med H Martinez-Diaz 127 1187 2003 10.5858/2003-127-1187-GCGAPX Martinez-Diaz H, Kleinschmidt-DeMasters BK, Powell SZ, Yachnis AT (2003) Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch Pathol Lab Med 127:1187-1191
Cancer Biol Ther PS Mischel 2 242 2003 10.4161/cbt.2.3.369 Mischel PS, Nelson SF, Cloughesy TF (2003) Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy. Cancer Biol Ther 2:242-247
Oncogene PS Mischel 22 2361 2003 10.1038/sj.onc.1206344 Mischel PS, Shai R, Shi T, Horvath S, Lu KV, Choe G, Seligson D, Kremen TJ, Palotie A, Liau LM, Cloughesy TF, Nelson SF (2003) Identification of molecular subtypes of glioblastoma by gene expression profiling. Oncogene 22:2361-2373
Cancer Res CL Nutt 63 1602 2003 Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN (2003) Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63:1602-1607
J Child Neurol JR Parker 16 548 2001 10.1177/088307380101600802 Parker JR, Armstrong DL, Strother D, Rudman DM, Dauser RC, Laurent JP, Deyd J, Rouah PE (2001) Antineuronal nuclei immunohistochemical staining patterns in childhood ependymomas. J Child Neurol 16:548-552
Neuroscience S Patt 71 601 1996 10.1016/0306-4522(95)00468-8 Patt S, Labrakakis C, Bernstein M, Weydt P, Cervos-Navarro J, Nisch G, Kettenmann H (1996) Neuron-like physiological properties of cells from human oligodendroglial tumors. Neuroscience 71:601-611
J Neuropathol Exp Neurol A Perry 61 947 2002 10.1093/jnen/61.11.947 Perry A, Scheithauer BW, Macaulay RJ, Raffel C, Roth KA, Kros JM (2002) Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol 61:947-955
Cancer Cell HS Phillips 9 157 2006 10.1016/j.ccr.2006.02.019 Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157-173
Am J Surg Pathol SZ Powell 20 80 1996 10.1097/00000478-199601000-00009 Powell SZ, Yachnis AT, Rorke LB, Rojiani AM, Eskin TA (1996) Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors. Am J Surg Pathol 20:80-85
Acta Neuropathol FJ Rodriguez 113 313 2007 10.1007/s00401-006-0153-x Rodriguez FJ, Scheithauer BW, Robbins PD, Burger PC, Hessler RB, Perry A, Abell-Aleff PC, Mierau GW (2007) Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum. Acta Neuropathol 113:313-324
Virchows Arch J Shibahara 447 665 2005 10.1007/s00428-005-1263-x Shibahara J, Fukayama M (2005) Secondary glioblastoma with advanced neuronal immunophenotype. Virchows Arch 447:665-668
J Neurooncol H Takeuchi 91 33 2009 10.1007/s11060-008-9690-6 Takeuchi H, Kubota T, Kitai R, Matsuda K, Hashimoto N, Sato K (2009) Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component. J Neurooncol 91:33-38
Am J Pathol T Tohyama 142 883 1993 Tohyama T, Lee VM, Trojanowski JQ (1993) Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines. Am J Pathol 142:883-892
Neurosurgery P Varlet 55 1377 2004 10.1227/01.NEU.0000143033.36582.40 Varlet P, Soni D, Miquel C, Roux FX, Meder JF, Chneiweiss H, Daumas-Duport C (2004) New variants of malignant glioneuronal tumors: a clinicopathological study of 40 cases. Neurosurgery 55:1377-1391, discussion 1391-1372
Histopathology M Vyberg 50 887 2007 10.1111/j.1365-2559.2007.02686.x Vyberg M, Ulhoi BP, Teglbjaerg PS (2007) Neuronal features of oligodendrogliomas-an ultrastructural and immunohistochemical study. Histopathology 50:887-896
Neuropathol Appl Neurobiol SB Wharton 24 302 1998 10.1046/j.1365-2990.1998.00132.x Wharton SB, Chan KK, Hamilton FA, Anderson JR (1998) Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study. Neuropathol Appl Neurobiol 24:302-308
Acta Neuropathol SB Wharton 100 695 2000 10.1007/s004010000241 Wharton SB, Lammie GA, Collie DA, Whittle IR (2000) The significance of intratumoural neurones and neuronal differentiation in diffuse gliomas: a case series. Acta Neuropathol 100:695-700
J Clin Neurosci SB Wharton 9 165 2002 10.1054/jocn.2001.1055 Wharton SB, Chan KK, Whittle IR (2002) Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas. J Clin Neurosci 9:165-169
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.